Patton Albertson Miller Group, LLC Pfizer Inc Transaction History

Patton Albertson Miller Group, LLC

  • $746 Million
  • Q2 2025

A detailed history of Patton Albertson Miller Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Patton Albertson Miller Group, LLC holds 21,572 shares of PFE stock, worth $590,425. This represents 0.07% of its overall portfolio holdings.

Number of Shares
21,572
Previous 21,787 0.99%
Holding current value
$590,425
Previous $552,000 5.43%
% of portfolio
0.07%
Previous 0.08%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 17, 2025
SELL
$21.59 - $24.84 $4,641 - $5,340
-215 Reduced 0.99%
21,572 $522,000
Q1 2025

May 02, 2025
BUY
$25.01 - $27.13 $29,986 - $32,528
1,199 Added 5.82%
21,787 $552,000
Q4 2024

Jan 21, 2025
SELL
$24.8 - $30.19 $96,620 - $117,620
-3,896 Reduced 15.91%
20,588 $546,000
Q3 2024

Nov 13, 2024
SELL
$27.7 - $31.39 $21,024 - $23,825
-759 Reduced 3.01%
24,484 $708,000
Q2 2024

Aug 02, 2024
SELL
$25.26 - $29.6 $2.58 Million - $3.02 Million
-101,985 Reduced 80.16%
25,243 $706,000
Q1 2024

Apr 24, 2024
BUY
$25.89 - $29.73 $596,376 - $684,830
23,035 Added 22.11%
127,228 $3.53 Million
Q4 2023

Feb 07, 2024
SELL
$26.13 - $33.94 $857,246 - $1.11 Million
-32,807 Reduced 23.95%
104,193 $3 Million
Q3 2023

Oct 24, 2023
SELL
$32.09 - $37.51 $34,946 - $40,848
-1,089 Reduced 0.79%
137,000 $4.54 Million
Q2 2023

Jul 13, 2023
SELL
$36.12 - $41.79 $188,799 - $218,436
-5,227 Reduced 3.65%
138,089 $5.07 Million
Q1 2023

Apr 21, 2023
BUY
$39.39 - $51.28 $108,677 - $141,481
2,759 Added 1.96%
143,316 $5.85 Million
Q4 2022

Jan 23, 2023
SELL
$41.75 - $54.5 $102,371 - $133,634
-2,452 Reduced 1.71%
140,557 $0
Q3 2022

Oct 13, 2022
BUY
$43.76 - $53.42 $75,836 - $92,576
1,733 Added 1.23%
143,009 $6.26 Million
Q2 2022

Jul 22, 2022
SELL
$46.53 - $55.17 $73,284 - $86,892
-1,575 Reduced 1.1%
141,276 $7.41 Million
Q1 2022

May 02, 2022
SELL
$45.75 - $56.69 $231,266 - $286,567
-5,055 Reduced 3.42%
142,851 $7.4 Million
Q4 2021

Feb 11, 2022
BUY
$41.32 - $61.25 $547,779 - $811,991
13,257 Added 9.85%
147,906 $8.73 Million
Q3 2021

Oct 27, 2021
BUY
$39.25 - $50.42 $1.07 Million - $1.37 Million
27,253 Added 25.38%
134,649 $5.79 Million
Q2 2021

Jul 29, 2021
BUY
$35.91 - $40.68 $42,553 - $48,205
1,185 Added 1.12%
107,396 $4.21 Million
Q1 2021

Apr 21, 2021
BUY
$33.49 - $37.77 $3,415 - $3,852
102 Added 0.1%
106,211 $3.85 Million
Q4 2020

Feb 25, 2021
SELL
$33.47 - $42.56 $6,961 - $8,852
-208 Reduced 0.2%
106,109 $3.68 Million
Q3 2020

Nov 03, 2020
BUY
$31.75 - $37.25 $34,639 - $40,639
1,091 Added 1.04%
106,317 $3.9 Million
Q2 2020

Aug 10, 2020
BUY
$30.12 - $36.54 $112,016 - $135,892
3,719 Added 3.66%
105,226 $3.44 Million
Q1 2020

May 22, 2020
BUY
$27.03 - $38.62 $102,308 - $146,176
3,785 Added 3.87%
101,507 $3.31 Million
Q4 2019

Feb 06, 2020
BUY
$32.92 - $37.36 $248,941 - $282,516
7,562 Added 8.39%
97,722 $3.83 Million
Q3 2019

Nov 13, 2019
BUY
$32.49 - $42.13 $143,280 - $185,793
4,410 Added 5.14%
90,160 $3.24 Million
Q2 2019

Aug 12, 2019
BUY
$36.98 - $41.52 $2.29 Million - $2.57 Million
61,851 Added 258.8%
85,750 $3.12 Million
Q1 2019

May 10, 2019
BUY
$37.5 - $41.2 $353,775 - $388,680
9,434 Added 65.22%
23,899 $1.02 Million
Q4 2018

Feb 12, 2019
BUY
$38.47 - $43.86 $320,455 - $365,353
8,330 Added 135.78%
14,465 $603,000
Q3 2018

Oct 25, 2018
BUY
$34.47 - $41.81 $19,234 - $23,329
558 Added 10.01%
6,135 $261,000
Q2 2018

Aug 10, 2018
BUY
$32.98 - $35.16 $183,929 - $196,087
5,577 New
5,577 $202,000
Q4 2017

Feb 02, 2018
SELL
$33.26 - $35.29 $218,751 - $232,102
-6,577 Closed
0 $0
Q3 2017

Oct 06, 2017
BUY
$31.0 - $34.15 $203,887 - $224,604
6,577
6,577 $237,000

Others Institutions Holding PFE

# of Institutions
3,296
Shares Held
3.66B
Call Options Held
96M
Put Options Held
121M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Patton Albertson Miller Group, LLC Portfolio

Follow Patton Albertson Miller Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patton Albertson Miller Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patton Albertson Miller Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email